Other OTC - Delayed Quote • USD
Avivagen Inc. (VIVXF)
At close: May 9 at 3:12 PM EDT
Breakdown
TTM
10/31/2022
10/31/2021
10/31/2020
Total Revenue
715.2190
939.1730
1,295.9910
1,177.8570
Cost of Revenue
409.8330
538.8740
761.6510
706.8770
Gross Profit
305.3850
400.2990
534.3400
470.9800
Operating Expense
1,504.9630
1,933.9960
1,891.9900
3,857.9730
Operating Income
-1,199.5780
-1,533.6970
-1,357.6500
-3,386.9930
Net Non Operating Interest Income Expense
-1,721.0210
-1,168.4500
-2,246.5420
-1,337.0170
Other Income Expense
-1,717.0940
-3,364.0590
-2,789.9670
-27.2770
Pretax Income
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
Net Income Common Stockholders
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
Diluted NI Available to Com Stockholders
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
Basic EPS
-0.06
-0.09
-0.12
-0.12
Diluted EPS
-0.06
-0.09
-0.12
-0.12
Basic Average Shares
69,374.2270
66,027.8610
52,444.1570
40,307.5790
Diluted Average Shares
69,374.2270
66,027.8610
52,444.1570
40,307.5790
Total Expenses
1,914.7960
2,472.8700
2,653.6410
4,564.8500
Net Income from Continuing & Discontinued Operation
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
Normalized Income
-2,922.8070
-2,702.1470
-3,644.1920
-4,751.2870
Interest Income
0.3520
0.6800
4.6910
9.0070
Interest Expense
1,861.1380
1,768.6170
1,586.0300
1,215.2400
Net Interest Income
-1,721.0210
-1,168.4500
-2,246.5420
-1,337.0170
EBIT
-2,778.7630
-4,297.5890
-4,808.1290
-3,536.0470
EBITDA
-2,717.3740
-4,210.0900
-4,683.3550
-3,408.5540
Reconciled Cost of Revenue
409.8330
538.8740
761.6510
706.8770
Reconciled Depreciation
61.3890
87.4990
124.7740
127.4930
Net Income from Continuing Operation Net Minority Interest
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
Total Unusual Items Excluding Goodwill
-1,717.0940
-3,364.0590
-2,749.9670
--
Total Unusual Items
-1,717.0940
-3,364.0590
-2,749.9670
--
Normalized EBITDA
-1,000.2800
-846.0310
-1,933.3880
-3,408.5540
10/31/2020 - 5/2/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SKYI Sky Century Investment, Inc.
0.0035
0.00%
PJET Priority Aviation, Inc.
0.0001
0.00%
TMSH TransGlobal Assets Inc.
0.0003
-16.67%
AOXG Aoxing Pharmaceutical Company, Inc.
0.0072
0.00%
FITX Creative Edge Nutrition, Inc.
0.0000
0.00%
SNNC Sibannac, Inc.
0.0080
+4.88%
KALY Kali, Inc.
0.0000
0.00%
RMRK Rimrock Gold Corp.
0.0004
0.00%
NNRX Nutranomics, Inc.
0.0000
0.00%
EAPH Parallel Industries Inc.
0.0000
0.00%